We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-20.88%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$377M
AUM Growth
-$204M
Cap. Flow
-$90.4M
Cap. Flow %
-23.98%
Top 10 Hldgs %
43.04%
Holding
146
New
4
Increased
24
Reduced
60
Closed
45

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$4.89M
2
GVA icon
Granite Construction
GVA
+$3.96M
3
TSM icon
TSMC
TSM
+$3.4M
4
VZ icon
Verizon
VZ
+$3.35M
5
AVGO icon
Broadcom
AVGO
+$3.21M

Sector Composition

Rank Sector Weight
1 Healthcare 35.22%
2 Technology 22.17%
3 Industrials 21.7%
4 Utilities 6.56%
5 Communication Services 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$27.9M 7.39%
584,619
-10,120
-2% -$666K
BMY icon
2
Bristol-Myers Squibb
BMY
$136B
$22.9M 6.07%
410,483
-4,265
-1% -$261K
GLW icon
3
Corning
GLW
$128B
$18.2M 4.83%
885,963
+1,187
+0.1% +$31K
PFE icon
4
Pfizer
PFE
$159B
$17.5M 4.65%
565,543
+51,226
+10% +$1.75M
GSK icon
5
GSK
GSK
$102B
$16.2M 4.29%
341,140
+91,640
+37% +$4.89M
INTC icon
6
Intel
INTC
$473B
$13.3M 3.54%
246,618
-51,995
-17% -$3.08M
NVS icon
7
Novartis
NVS
$292B
$12.6M 3.34%
152,835
-2,515
-2% -$224K
JNJ icon
8
Johnson & Johnson
JNJ
$646B
$12.2M 3.22%
92,684
-284
-0.3% -$40.3K
MMM icon
9
3M
MMM
$89.9B
$11M 2.93%
96,694
-837
-0.9% -$110K
LGTY
10
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$10.5M 2.78%
738,573
-12,683
-2% -$188K
BCE icon
11
BCE
BCE
$21.9B
$10.1M 2.68%
246,827
+19,076
+8% +$855K
OGE icon
12
OGE Energy
OGE
$9.45B
$8.98M 2.38%
292,258
+12,140
+4% +$491K
XRAY icon
13
Dentsply Sirona
XRAY
$2.22B
$8.19M 2.17%
211,000
-1,900
-0.9% -$96.8K
MDU icon
14
MDU Resources
MDU
$4.16B
$8.1M 2.15%
990,583
-11,264
-1% -$119K
LNN icon
15
Lindsay Corp
LNN
$1.16B
$7.99M 2.12%
87,257
-22,861
-21% -$2.25M
IBM icon
16
IBM
IBM
$222B
$7.92M 2.1%
74,690
+4,341
+6% +$549K
MSFT icon
17
Microsoft
MSFT
$3.81T
$6.86M 1.82%
43,482
-14,105
-24% -$2.32M
ABT icon
18
Abbott
ABT
$195B
$6.78M 1.8%
85,911
-2,506
-3% -$209K
TMO icon
19
Thermo Fisher Scientific
TMO
$230B
$6.58M 1.75%
23,204
-484
-2% -$153K
MRK icon
20
Merck
MRK
$366B
$6.3M 1.67%
85,854
-151
-0.2% -$11.9K
GVA icon
21
Granite Construction
GVA
$5.44B
$5.92M 1.57%
389,916
+176,491
+83% +$3.96M
ADM icon
22
Archer Daniels Midland
ADM
$39.3B
$5.46M 1.45%
155,350
BNS icon
23
Scotiabank
BNS
$113B
$5.36M 1.42%
132,125
-24,650
-16% -$1.25M
HON icon
24
Honeywell
HON
$68.9B
$5.35M 1.42%
42,441
-345
-0.8% -$53.3K
LITE icon
25
Lumentum
LITE
$80.3B
$5.33M 1.42%
72,378
-18,006
-20% -$1.42M

Similar funds

John G. Ullman & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, John G. Ullman & Associates held 146 positions worth $377M, down 35% from $581M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

John G. Ullman & Associates withdrew a net $90.4M in Q1 2020, closing 45 positions and reducing 60 holdings. Its most notable exit was iShares MSCI Emerging Markets Min Vol Factor ETF, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Broadcom worth $2.7M.

  • John G. Ullman & Associates's largest Q1 2020 buy was Broadcom: 114,000 shares worth $2.7M.
  • John G. Ullman & Associates added most to GSK in Q1 2020, an estimated $4.89M increase.
  • John G. Ullman & Associates's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $9.24M.
  • John G. Ullman & Associates fully exited iShares MSCI Emerging Markets Min Vol Factor ETF in Q1 2020, selling an estimated $11.9M.
  • John G. Ullman & Associates's ten largest holdings make up 43% of its $377M portfolio in Q1 2020.
  • John G. Ullman & Associates opened 4 new positions and closed 45 in Q1 2020.
  • John G. Ullman & Associates's portfolio value fell 35% quarter-over-quarter to $377M.

Based on John G. Ullman & Associates's 13F filing for Q1 2020, filed 14 Apr 2020.